Furthermore, the study suggests potential therapeutic implications of ANGPTL3 inhibition for both hypothyroidism and hyperthyroidism, alongside the observed risk increase in hyperthyroidism with LPL activation. This evidence concerns the gene ANGPTL3 and hyperthyroidism.